Filter
1946
Filtered Results: 1946
Text search:
drug
use
disorders
Featured
Recommendations
218
New Publications
418
Language
Document type
No document type
1259
Guidelines
251
Studies & Reports
242
Manuals
89
Strategic & Response Plan
39
Fact sheets
25
Training Material
23
Infographics
5
Brochures
4
Situation Updates
4
Resource Platforms
3
Dashboards/Maps
1
Online Courses
1
Countries / Regions
India
130
Global
62
Western and Central Europe
55
South Africa
47
Ethiopia
46
Kenya
42
Nigeria
35
Ukraine
31
Latin America and the Carribbean
28
Eastern Europe
26
Philippines
25
Uganda
25
Nepal
24
Tanzania
23
Ghana
22
Rwanda
22
Bangladesh
22
Liberia
21
Malawi
20
Zambia
19
Myanmar / Burma
19
Sierra Leone
18
Africa
16
Russia
16
Namibia
16
South–East Asia Region
13
USA
12
Indonesia
12
Eswatini/ Swaziland
11
Syria
10
Asia
10
Lesotho
9
Germany
8
Brazil
8
Botswana
8
Zimbabwe
7
Tajikistan
6
Haiti
6
South Sudan
6
Mozambique
5
Cambodia
5
Congo, Democratic Republic of
5
North Macedonia
4
Cameroon
4
Eastern Europe and Central Asia
4
Sudan
4
Georgia
4
China
3
Afghanistan
3
Middle East and North Africa
3
Belarus
3
East and Southern Africa
3
Iraq
3
Thailand
2
Albania
2
Canada
2
Laos
2
Senegal
2
Kyrgyzstan
2
Jordan
2
West and Central Africa
2
Western Pacific Region
2
Jamaica
2
United Kingdom
2
Vietnam
2
Papua New Guinea
2
Moldova
2
Sri Lanka
2
Pakistan
2
Switzerland
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
Kazakhstan
1
Iran
1
Fiji
1
Singapore
1
Estonia
1
Burkina Faso
1
Uzbekistan
1
Peru
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Guinea
1
Armenia
1
Venezuela
1
Hungary
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Turkmenistan
1
Belgium
1
Tunisia
1
Southern Africa
1
Bolivia
1
Lebanon
1
Yemen
1
Greece
1
Palestine
1
Poland
1
Honduras
1
Angola
1
Libya
1
Bhutan
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
635
Clinical Guidelines
188
Public Health
120
Women & Child Health
101
Key Resources
41
Capacity Building
37
Pharmacy & Technologies
15
Annual Report MEDBOX
1
Toolboxes
Mental Health
576
HIV
117
TB
85
NCDs
70
COVID-19
63
Pharmacy
53
NTDs
49
Disability
43
Caregiver
38
Refugee
37
Planetary Health
28
Conflict
26
Rapid Response
23
Global Health Education
20
AMR
20
Zika
15
Ebola & Marburg
12
Specific Hazards
9
Natural Hazards
6
Polio
5
Social Ethics
4
Health Financing Toolbox
3
Cholera
2
The WHO Global Burden of Disease (GBD) study measures the burden of
disease using the disability-adjusted life year metric (DALY). The DALY metric
was developed to assess the burden of disease consistently across diseases,
risk factors and regions. A consistent and comparative description of the ...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large...
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.
This block contains a wide variety of disorders that differ in severity (from uncomplicated intoxication and harmful use to obvious psychotic disorders and dementia), but that are all attributable to the use of one or more psychoactive substances (which may or may not have been medically prescribed)
As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training of health-care providers training manual) to support implementation of the mhGAP Intervention Guide for mental, neurological and substance use (MNS...
Petersen et al. Int J Ment Health Syst (2016) 10:30 DOI 10.1186/s13033-016-0060-z
Mental disorders are important public health concern in Bangladesh with a substantial treatment gap due to shortage of resources and trained relevant professionals, such as psychiatrists, psychologists, social psychologists, psychiatric nurses and occupational therapists.
This manual is developed i...
Substance use disorders
Chapter G.3
Other disorders
Chapter H.6
In this entry we are looking at smoking, alcohol consumption and the use of illicit drugs. We are studying who is using these substances, how their use has changed over time, and we are presenting the estimates of their impact on health. Collectively, smoking, alcohol and illicit drug use kills 11.8...
Module: Disorders due to substance abuse mhGAP
recommended
Accessed: 21.03.2019
mhGAP Training Manual for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings – version 2.0 (for field testing)
The new guide provides practical, first-line management recommendations for mental, neurological and substance use conditions. Contents include modules on assessing and managing conditions such as acute stress, grief, moderate-severe depressive disorder, post-traumatic stress disorder, epilepsy, and...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply...
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi...
Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one antipsychotic only?
Version: 14 March 2019; A one-page reference guide to all the anti-HIV drugs licensed for use in the European Union, with information on formulation, dosing, key side-effects and food restrictions.
The previous edition of the drugs chart is also available to download in Russian.
Fetal alcohol spectrum disorders (FASD) represent a range of physical, mental, and behavioral disabilities caused by alcohol use during pregnancy, or prenatal alcohol exposure (PAE). FASDs are considered to be one of the leading preventable causes of developmental disability. Despite its high preval...
The guideline on Drug misuse: opioid detoxification, commissioned by NICE and developed by the National Collaborating Centre for Mental Health, sets out clear, evidence-based recommendations for healthcare staff on how to work with people who misuse opioids to significantly improve their treatment a...
